ATOVAQUONE
NDC 70748-299, ATOVAQUONE, suspension, from Lupin Pharmaceuticals, Inc..
- Product NDC
- 70748-299
- Status
- Listed
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210692
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70748-299 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATOVAQUONE750 mg/5mL
Pharmacologic classes
Antimalarial [EPC]; Antiprotozoal [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70748-299-01 | 70748029901 | 1 BOTTLE in 1 CARTON (70748-299-01) / 210 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/03ddcc33-729c-4d46-ae6b-2ee47978ba16
Use it
Look up 70748-299 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70748-299 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70748-299. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.